newsfilter
← Latest News
GlobeNewswire·

Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023

SEATTLE, May 05, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ:IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet